高强度聚焦超声对子宫肌瘤和子宫腺肌病患者卵巢储备的影响:系统综述与单臂Meta分析
本系统综述与单臂Meta分析纳入10项研究(2项RCT和8项病例系列,共667例),评估HIFU治疗后卵巢储备标志物的变化。汇总分析显示血清AMH水平小幅但显著下降(MD=-0.12 ng/mL,95%CI -0.20至-0.04),而AFC无显著变化(MD=-0.05,95%CI -0.28至0.19)。证据主要来自非对照前后研究,不能确立因果关系,建议结合AFC和临床背景评估卵巢储备。
要点
- HIFU治疗后血清AMH小幅下降,AFC无显著变化,评估卵巢储备不应仅依赖AMH。
- 证据主要来自非对照前后研究,AMH下降与HIFU的因果关系未证实。
- 对卵巢储备减退或高龄女性,治疗前咨询需关注即使微小下降的临床意义。
核心结论
- HIFU治疗后血清AMH水平小幅但显著下降,AFC无显著变化,但证据主要来自非对照研究,不能证明因果关系。
研究设计与样本
- 系统综述与单臂Meta分析,纳入2项随机对照试验和8项病例系列,共667例,随访3至24个月。
- 检索MEDLINE、Scopus和CENTRAL从建库至2026年1月5日,由两名评价者独立筛选文献并评估偏倚风险。
诊断标准与关键数值
- 汇总分析显示血清AMH水平下降(MD=-0.12 ng/mL;95%CI -0.20至-0.04,I2=0%)。
- AFC汇总分析(2项研究,n=140)无显著变化(MD=-0.05;95%CI -0.28至0.19,I2=0%)。
- 仅限子宫肌瘤的研究中AMH下降持续存在(MD=-0.13 ng/mL;95%CI -0.22至-0.05),子宫腺肌病数据不足。
临床应用与阅片要点
- HIFU治疗后卵巢储备评估应结合AMH、AFC和临床背景,不应仅依赖AMH。
- 对卵巢储备减退或高龄女性,治疗前咨询应告知AMH可能小幅下降及其潜在临床意义。
局限性
- 证据主要来自非对照前后研究,无法确立HIFU与AMH下降的因果关系。
- 子宫腺肌病特异性数据不足,无法单独估计该人群的效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The aim of the study is to evaluate the effect of high-intensity focused ultrasound (HIFU) treatment on ovarian reserve by synthesizing available evidence on post-treatment changes in ovarian reserve markers. Studies were eligible if they evaluated the impact of HIFU on ovarian reserve by reporting pre- and post-treatment ovarian reserve markers, including anti-Müllerian hormone (AMH), antral follicle count (AFC), or gonadotropin levels. MEDLINE, Scopus, and CENTRAL were searched from inception to January 5, 2026. Two reviewers independently screened titles and abstracts, assessed full texts, and evaluated risk of bias using the Cochrane Risk-of-Bias tool for randomized trials or the JBI critical appraisal tool for case series. Disagreements were resolved through discussion or consultation with a third reviewer. Of 2498 records identified, 1935 were screened after removal of duplicates, 24 articles underwent full-text review, and 10 studies were included in the systematic review and single-arm meta-analysis. This review included 2 randomized controlled trials and 8 case series (n = 667). The duration of follow-up after HIFU ranged between 3 and 24 months. Overall pooled analysis of all studies showed a small but statistically significant reduction in serum AMH levels (MD = -0.12 ng/mL; 95% CI = -0.20 to -0.04, I2 = 0%). Pooled analysis of AFC (2 studies, n = 140) revealed no statistically significant change after HIFU treatment (MD = -0.05; 95% CI = -0.28 to 0.19; I2 = 0%). The reduction in AMH persisted when the analysis was restricted to fibroid-only studies (MD = -0.13 ng/mL; 95% CI = -0.22 to -0.05), whereas data were insufficient for an adenomyosis-specific estimate. Pooled single-arm analysis showed a small but statistically significant reduction in serum AMH levels following HIFU treatment, with no significant change in AFC. This decline was associated with, rather than proven to be caused by, HIFU treatment, as the available evidence derives predominantly from uncontrolled pre-post studies that cannot establish causality. Therefore, evaluation of ovarian reserve after HIFU should not rely on AMH alone but incorporate AFC and clinical context. Pre-treatment counseling is particularly important in women with diminished ovarian reserve or of late reproductive age, in whom even minor reductions may be clinically relevant.
引用
- Karadeniz O, Kar E, Cicekyurt DT, et al. The Impact of High Intensity Focused Ultrasound on Ovarian Reserve in Women with Uterine Fibroids and Adenomyosis: A Systematic Review and Single Arm Meta-Analysis. J Ultrasound Med. 2026. PMID: 42944603. doi:10.1002/jum.70531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。